PMID- 25070833 OWN - NLM STAT- MEDLINE DCOM- 20151006 LR - 20211021 IS - 1573-4919 (Electronic) IS - 0300-8177 (Linking) VI - 396 IP - 1-2 DP - 2014 Nov TI - Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARgamma activity in type 2 diabetic rats. PG - 161-74 LID - 10.1007/s11010-014-2152-x [doi] AB - Type 2 Diabetes mellitus (T2DM) is characterized by peripheral insulin resistance, impaired insulin secretion, and reduced beta-cell mass. Mechanisms that underlie beta-cell failure include glucotoxicity, lipotoxicity, endoplasmic reticulum (ER) stress, and oxidative stress. This study was designed to assess the protective effect of trigonelline and diosgenin against changes in ER stress-associated apoptotic proteins CHOP, Caspase12, and Caspase3 and antioxidant levels in pancreas as well as adipose tissue PPARgamma mRNA in T2DM rats. Markers of diabetes and obesity such as serum glucose, insulin, free fatty acid (FFA), TNF-alpha, IL-6, and leptin were also assessed. T2DM rats showed significantly elevated levels of pancreatic ER stress proteins and lipid peroxidation, while the antioxidants were significantly reduced. Histological examination also confirmed T2DM-associated damage in pancreas. In addition, a significant increase in serum FFA, TNF-alpha, IL-6, and decrease in leptin levels along with significantly decreased adipose mass and reduced PPARgamma expression were observed in T2DM rats. On the other hand, trigonelline and diosgenin treatment independently brought about significant improvement in serum parameters, decrease in apoptotic ER stress proteins, and reinforced antioxidant status in pancreas. Histological examination of pancreas showed normal morphology. Treated groups also showed increased adipose tissue mass and enhanced PPARgamma expression. Data from docking studies indicated good interaction of both compounds with PPARgamma, and diosgenin showed better binding efficiency. These findings suggest that the insulin-sensitizing effects of trigonelline and diosgenin are mediated through moderation of ER stress and oxidative stress in pancreas as well as by PPARgamma activation in adipose tissue. FAU - Tharaheswari, M AU - Tharaheswari M AD - Department of Biochemistry and Molecular Biology, School of Life Sciences, Pondicherry University, Puducherry, India. FAU - Jayachandra Reddy, N AU - Jayachandra Reddy N FAU - Kumar, R AU - Kumar R FAU - Varshney, K C AU - Varshney KC FAU - Kannan, M AU - Kannan M FAU - Sudha Rani, S AU - Sudha Rani S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140729 PL - Netherlands TA - Mol Cell Biochem JT - Molecular and cellular biochemistry JID - 0364456 RN - 0 (Alkaloids) RN - 0 (Insulin) RN - 0 (Interleukin-6) RN - 0 (Leptin) RN - 0 (PPAR gamma) RN - 0 (Tumor Necrosis Factor-alpha) RN - 3NQ9N60I00 (trigonelline) RN - K49P2K8WLX (Diosgenin) SB - IM MH - Adipose Tissue/*drug effects/metabolism MH - Alkaloids/chemistry/*pharmacology MH - Animals MH - Diabetes Mellitus, Experimental/drug therapy/metabolism MH - Diabetes Mellitus, Type 2/*drug therapy/metabolism MH - Diet, High-Fat MH - Diosgenin/chemistry/*pharmacology MH - Endoplasmic Reticulum Stress/*drug effects MH - Insulin/blood MH - Interleukin-6/blood MH - Leptin/blood MH - Male MH - Molecular Docking Simulation MH - Oxidative Stress/drug effects MH - PPAR gamma/chemistry/genetics/*metabolism MH - Pancreas/drug effects/pathology MH - Rats, Sprague-Dawley MH - Tumor Necrosis Factor-alpha/blood EDAT- 2014/07/30 06:00 MHDA- 2015/10/07 06:00 CRDT- 2014/07/30 06:00 PHST- 2014/04/16 00:00 [received] PHST- 2014/07/11 00:00 [accepted] PHST- 2014/07/30 06:00 [entrez] PHST- 2014/07/30 06:00 [pubmed] PHST- 2015/10/07 06:00 [medline] AID - 10.1007/s11010-014-2152-x [doi] PST - ppublish SO - Mol Cell Biochem. 2014 Nov;396(1-2):161-74. doi: 10.1007/s11010-014-2152-x. Epub 2014 Jul 29.